GSK US engagement report
@GSKUS - 95K followers on X
Measured over 1 original post from a 30-day window, last computed on September 17, 2026.
Engagement
Early reading. We have captured 1 original post for this account, below the 8 we require before treating a median as settled. The numbers above describe what we have seen so far, not a finished profile of the account.
A typical post picks up 6 interactions against 95K followers, an engagement rate of 0.006%. Posts are seen about 1.5K times each, and 0.401% of those impressions turn into an interaction. That is about 1.58% of the follower count, which is the gap between an audience on paper and an audience in a timeline. Posting runs at about 0.03 posts a day over the last 30 days, though only 3% of days saw any activity at all. Most posts go out around 11:00 UTC, and Monday is the busiest day of the week. Of the 1 posts sampled, 100% carry an image or video and 100% link out. The account's strongest tracked post pulled 13 interactions, about 2.2x its own typical post. Recurring topics include #investors, #media, #news. Only 1 original post have been captured so far, fewer than the 8 posts we want behind a median before treating it as settled. Read the figures above as an early measurement of this account, not as a finished profile of it.
Measured over 1 original post from a 30-day window, last computed on September 17, 2026. Recurring tags: #investors, #media, #news.
Where this sits in the catalog
At 0.006%, GSK US sits above the 10th percentile of the 213,186 accounts in this comparison. That places it in the bottom 25% band, which runs below 0.025%.
Show the percentile table
| Percentile | Engagement rate |
|---|---|
| 10th percentile | 0.004% |
| 25th percentile | 0.025% |
| 50th percentile | 0.147% |
| 75th percentile | 0.698% |
| 90th percentile | 2.61% |
| 99th percentile | 82.9% |
This ruler is the whole measured catalog, not a size-matched group: it shows where the raw rate falls across every account we can measure, all of which are large. For a like-for-like comparison, read the size-band percentile above instead. See how the bands are built
Posting timing
This account posts most often around 11:00 UTC, and Monday is its busiest day of the week. The bars below are the catalog-wide pattern, with this account's own busiest slot marked. They do not show how this account performs at each hour: we keep one aggregate per account, not one per hour, so that measurement does not exist in our data.
Show engagement by hour posted, utc as a table
| Hour (UTC) | Vs author median | Posts |
|---|---|---|
| 00:00 UTC | -1% | 89K |
| 01:00 UTC | -2% | 90K |
| 02:00 UTC | -3% | 88K |
| 03:00 UTC | -4% | 94K |
| 04:00 UTC | -5% | 76K |
| 05:00 UTC | -4% | 75K |
| 06:00 UTC | -5% | 86K |
| 07:00 UTC | -5% | 93K |
| 08:00 UTC | -4% | 108K |
| 09:00 UTC | -4% | 124K |
| 10:00 UTC | -3% | 129K |
| 11:00 UTC | -3% | 141K |
| 12:00 UTC | -3% | 154K |
| 13:00 UTC | -3% | 167K |
| 14:00 UTC | -4% | 173K |
| 15:00 UTC | -2% | 176K |
| 16:00 UTC | -3% | 171K |
| 17:00 UTC | -3% | 159K |
| 18:00 UTC | -2% | 149K |
| 19:00 UTC | -2% | 141K |
| 20:00 UTC | -1% | 131K |
| 21:00 UTC | 0% | 116K |
| 22:00 UTC | -2% | 100K |
| 23:00 UTC | -1% | 90K |
Show engagement by day of week as a table
| Day | Vs author median | Posts |
|---|---|---|
| Sunday | +5% | 393K |
| Monday | +1% | 483K |
| Tuesday | -2% | 520K |
| Wednesday | -3% | 472K |
| Thursday | -2% | 430K |
| Friday | -3% | 447K |
| Saturday | +2% | 393K |
Formats this account uses
Its own posting mix on the left, and what each of those formats does across every account we track on the right. Only formats where the effect clears our publish test appear here, so an empty row is a format we could not measure rather than one that does nothing.
| Format | This account | Catalog effect | 95% interval | Accounts behind it |
|---|---|---|---|---|
| Image or video | 100% of posts | +111% | +108% to +115% | 34K |
| Outbound link | 100% of posts | -41% | -42% to -40% | 32K |
| Typical length | - | no effect | -2% to -1% | 42K |
- 100% of this account's sampled posts carry an image or video. Across the catalog, posts with an image or video run 111% above the same accounts' other posts.
- 100% of its posts carry a link off X. Across the catalog, posts with an outbound link run 41% below the same accounts' other posts, so a large share of this account's output sits in the weakest bucket we measure.
- Its average post runs 211 characters, which falls in the 180 - 280 characters band. Across the catalog, posts of 180 to 280 characters match the same accounts' other posts almost exactly.
These are catalog-wide differences applied to this account's own posting mix, not a measurement of how each format performs for this account specifically. We keep one median per account, not one per format per account, so the second thing is not something this data can tell you.
Best tweets
- Oct 21, 20252.2x their median
"It takes over 10-12 years to bring a really big medicine to market - being able to change - by engineering biology - [will have] a massive impact on patients." @GSK's Shobie Ramakrishnan explores the intersection between tech and medicine at #BloombergTech. https://t.co/MPSGillpB3
- Dec 17, 20251.8x their median
#News for #Media and #Investors: The US Food and Drug Administration (FDA) has approved our new, long-acting biologic therapy for people living with severe asthma. For more information, visit: https://t.co/JUkTiwQ3Ps https://t.co/J4y4EiiOfK
- Sep 17, 20251.7x their median
We are investing $30 billion in R&D and manufacturing in the US over the next 5 years. This will create hundreds of new highly skilled jobs and builds on GSK’s strong innovation and manufacturing footprint in the US, developing and making products in the US for the US.
- Apr 1, 2026
Our partnership with the lupus community has always been fueled by a clear purpose: to improve the outcomes for people living with lupus. This dedication to advancing breakthroughs continues to drive our work as we look ahead to the future of lupus care. #Lupus #AheadTogether https://t.co/AZXLGfzBGv
- Dec 4, 2025
Big news for U.S. innovation! We've officially opened our new Vaccine & Infectious Disease R&D HQ in Boston's Cambridge Park Drive. This expanded space is central to our 5-year investment in the U.S., driving faster, better innovation for patients globally.
- Aug 24, 2026
#News for #Investors and #Media: Today, we announced the US FDA accepted the application for one of our immuno-oncology therapies for priority review. Learn more: https://t.co/ZrSf9EHCh5 https://t.co/Oq7v6Lq69d
- Feb 26, 2026
We’re on the ground at #AAAAI26, sharing our latest #RespiratoryHealth research this week. Stop by Booth 1137 to learn more. If you can’t attend, you can learn more about our work here: https://t.co/164aJaWugN 🫁 https://t.co/YLqQcHhrpd
- Jan 20, 2026
#News for #Media: Meet the Linked by Lupus: Optimal Care Initiative grant awardees; orgs working to improve early diagnosis, expand access to treatment, and strengthen patient-provider communications for those impacted by #lupus. Read more about the grant and awardees: https://t.co/phH0XSkIWz
- Dec 10, 2025
#News for #Investors and #Media: Today we announced that the Food and Drug Administration (FDA) has granted Orphan Drug Designation to an investigational antibody-drug conjugate in our oncology pipeline. Learn more here: https://t.co/XG0xgBbjcV https://t.co/DDRIVs8gRt
- May 15, 2026
Getting ahead of respiratory disease means relentless innovation, moving beyond just symptom management. At #ATS2026, we're sharing 33 abstracts across our respiratory portfolio. Our focus: targeting underlying drivers of conditions like asthma, COPD, and refractory chronic cough to improve patient outcomes. Explore our science – a meaningful investment for patients, health systems, and societies.
Ranked by total interactions across everything we have tracked for this account, which is a longer history than the 30-day window the rates above use. The multiple compares each post to this account's own median.
Recurring topics
The most frequent hashtags in the sampled posts. They describe what this account writes about; they are not a performance signal, and the catalog-wide breakdown on the hub shows how little hashtag count moves.
Buy or sell Twitter (X) accounts - escrow-protected
PlayerSells is an escrow marketplace for Twitter (X) accounts. Every deal is protected, with no middleman risk.
Reading these numbers
A typical post picks up 6 interactions against 95K followers, an engagement rate of 0.006%. Posts are seen about 1.5K times each, and 0.401% of those impressions turn into an interaction. That is about 1.58% of the follower count, which is the gap between an audience on paper and an audience in a timeline. Posting runs at about 0.03 posts a day over the last 30 days, though only 3% of days saw any activity at all. Most posts go out around 11:00 UTC, and Monday is the busiest day of the week. Of the 1 posts sampled, 100% carry an image or video and 100% link out. The account's strongest tracked post pulled 13 interactions, about 2.2x its own typical post. Recurring topics include #investors, #media, #news. Only 1 original post have been captured so far, fewer than the 8 posts we want behind a median before treating it as settled. Read the figures above as an early measurement of this account, not as a finished profile of it.
- What is GSK US's engagement rate on X?
- GSK US (@GSKUS) has an engagement rate of 0.006%, based on the median interactions across 1 original posts from the last 30 days against 94,524 followers. Replies, reposts and quote-posts of other people are excluded from that sample.
- Is that a good engagement rate?
- At 0.006%, GSK US sits above the 10th percentile of the 213,186 accounts in this comparison. Those comparison accounts are all large ones, because our scanning cadence is weighted towards big accounts, so this is a ranking among peers of similar scale rather than a ranking across X.
- Does @GSKUS have real engagement?
- There is not yet enough sample to rank this account against others of its size.
- When does @GSKUS post?
- Most posts go out around 11:00 UTC, and Monday is its busiest day, at roughly 0.03 posts per day across the measured window.